Physician profile
Dee A Spade
NPI 1588609051
$2,406.19
in general payments reported to CMS, 2019-2025
14 companies · $308 in 2025
The $308 reported for 2025 was more than what 85% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $182 · 2021: $474 · 2022: $371 · 2023: $356 · 2024: $301 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $614.42 | 2021-2025 | Minimed 780g |
| Medtronic Minimed, INC. | $521.19 | 2019-2020 | |
| Novo Nordisk INC | $457.98 | 2021-2023 | Wegovy, Sogroya |
| Tandem Diabetes Care, INC. | $216.87 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Sanofi-Aventis U.S. LLC | $202.60 | 2023-2025 | |
| Abbott Laboratories | $165.94 | 2022 | |
| Dexcom, INC. | $67.10 | 2023 | Dexcom G6 Transmitter |
| Zealand Pharma US, INC. | $36.28 | 2021 | |
| Insulet Corporation | $33.18 | 2019-2024 | Omnipod |
| Abbvie INC. | $30.31 | 2019-2020 | |
| Senseonics, Incorporated | $19.00 | 2019-2020 | |
| Pfizer INC. | $15.25 | 2023 | |
| Endo USA, INC. | $14.82 | 2025 | Supprelin |
| Lilly USA, LLC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dee Spade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.